THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING
Around the Region

Cyberkinetics preparing to close shop

By Todd Wallack
Globe Staff / March 19, 2009
  • Email|
  • Print|
  • Single Page|
  • |
Text size +

Cyberkinetics Neurotechnology Systems Inc., a Foxborough medical device company, is winding down operations, said chief executive Tim Surgenor.

Surgenor said the company is selling off its assets to pay creditors. In January, the company sold rights to its main product, the Andara Oscillating Field Stimulator System, to NeuroMetrix Inc. in Waltham for $350,000. The device is intended to help regenerate nerve cells for people with severe spinal injuries.

Cyberkinetics hoped to market the device itself, but ran out of money while waiting two years for approval from the Food and Drug Administration. The FDA still has not rendered a decision on the product. "We didn't anticipate it taking so long," Surgenor said. "It's unfortunate."

NeuroMetrix said Surgenor will join its board April 1.

  • Email
  • Email
  • Print
  • Print
  • Single page
  • Single page
  • Reprints
  • Reprints
  • Share
  • Share
  • Comment
  • Comment
 
  • Share on DiggShare on Digg
  • Tag with Del.icio.us Save this article
  • powered by Del.icio.us
Your Name Your e-mail address (for return address purposes) E-mail address of recipients (separate multiple addresses with commas) Name and both e-mail fields are required.
Message (optional)
Disclaimer: Boston.com does not share this information or keep it permanently, as it is for the sole purpose of sending this one time e-mail.